Kezar Life Sciences Inc (NASDAQ:KZR)

2.88
Delayed Data
As of Jun 02
 +0.095 / +3.42%
Today’s Change
2.25
Today|||52-Week Range
11.02
-59.16%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$207.8M

Company Description

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Contact Information

Kezar Life Sciences, Inc.
4000 Shoreline Court
South San Francisco California 94080
P:(650) 822-5600
Investor Relations:

Employees

Shareholders

Other institutional53.96%
Mutual fund holders22.89%
Individual stakeholders18.83%

Top Executives

John FowlerChief Executive Officer & Director
Marc L. BelskyChief Financial Officer & Secretary
Noreen Roth HenigChief Medical Officer
Pattie ChiangVice President & Controller
Andrea FanVice President-Biology